Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 19.34
+0.14 (0.73%)
Sep 5, 2025, 5:35 PM CET
Guerbet Revenue
In the year 2024, Guerbet had annual revenue of 851.12M EUR with 6.97% growth. Guerbet had revenue of 426.19M in the half year ending December 31, 2024, with 7.81% growth.
Revenue
851.12M
Revenue Growth
+6.97%
P/S Ratio
0.29
Revenue / Employee
299.48K
Employees
2,905
Market Cap
243.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 851.12M | 55.46M | 6.97% |
| Dec 31, 2023 | 795.65M | 26.16M | 3.40% |
| Dec 31, 2022 | 769.50M | 33.59M | 4.56% |
| Dec 31, 2021 | 735.91M | 19.24M | 2.68% |
| Dec 31, 2020 | 716.67M | -102.33M | -12.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |